Actinomycosis¶
Chapter 180 | Part 5: Infectious Diseases
KEY CLINICAL POINTS¶
- Actinomycosis is a chronic, indolent infection caused by Actinomyces species, often mimicking malignancy due to its mass-like lesions and sulfur granules.
- Diagnosis is challenging due to its slow progression, association with foreign bodies (e.g., IUDs, bisphosphonates), and frequent misdiagnosis as cancer or tuberculosis.
- Prolonged antibiotic therapy (6–12 months) with penicillin or alternatives is the mainstay of treatment, with surgical intervention reserved for refractory cases.
- Imaging (CT/MRI) and microbiological identification of sulfur granules (via PAS/GMS stains) are critical for diagnosis.
- Complications include sinus tracts, abscesses, and dissemination to distant organs, though hematogenous spread is rare.
1. DEFINITION & OVERVIEW¶
Actinomycosis is a chronic, indolent infection caused by anaerobic/microaerophilic Actinomyces species, primarily affecting the oral, cervical, facial, thoracic, abdominal, and pelvic regions. It is characterized by sulfur granules, fibrotic abscesses, and sinus tracts, often mimicking malignancy. The infection is polymicrobial and typically occurs after mucosal disruption, with delayed diagnosis due to its slow progression.
1.1 Clinical Presentation¶
Common presentations include chronic indolent abscesses, sinus tracts, and mass-like lesions. Thoracic, abdominal, and pelvic forms are distinct, with thoracic disease often involving pleural thickening and empyema. Pelvic actinomycosis is frequently associated with IUDs or pelvic trauma.
1.2 Diagnostic Challenges¶
Diagnosis is often delayed due to its mimicry of malignancy, tuberculosis, and other infections. Sulfur granules in pus or biopsy specimens are diagnostic, but their absence may necessitate imaging (CT/MRI) and microbiological confirmation.
2. EPIDEMIOLOGY¶
Actinomycosis has no geographic boundaries and occurs across all ages, with peak incidence in middle age. Males are three times more likely to be affected due to poorer dental hygiene and trauma. Incidence has declined with antibiotics, but risk remains in individuals with IUDs, bisphosphonate use, or immunosuppression (e.g., HIV, organ transplant recipients).
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Etiologic agents include Actinomyces species (A. israelii, A. naeslundii, etc.) and other bacteria (e.g., Fusobacterium, Bacteroides). Pathogenesis involves mucosal disruption leading to contiguous spread, biofilm formation (sulfur granules), and chronic inflammation. Foreign bodies (IUDs, dental procedures) and immunosuppression (e.g., anti-TNF α , bisphosphonates) increase susceptibility.
3.1 Sulfur Granules¶
Characteristic sulfur granules (composed of Actinomyces, calcium phosphate, and host material) form in abscesses. They are diagnostic on microscopy but may be absent in disseminated disease.
3.2 Biofilm Formation¶
Sulfur granules represent biofilms that resist antibiotics and contribute to chronicity. Contiguous spread through tissue planes is common, with rare hematogenous dissemination.
4. CLINICAL FEATURES¶
Clinical manifestations vary by site: oral/cervicofacial (abscesses, sinus tracts), thoracic (pleural thickening, empyema), abdominal (abscesses, fistulas), and pelvic (masses, tuboovarian abscesses). Systemic symptoms include fever, weight loss, and leukocytosis. Misdiagnosis as cancer or tuberculosis is common due to indolent progression and mass-like features.
4.1 Thoracic Disease¶
Pulmonary involvement presents as cavitary lesions, pleural thickening, or empyema. CT shows low-attenuation masses with ring-enhancing rims. Dissemination to the mediastinum or heart is rare.
4.2 Abdominal Disease¶
Abdominal actinomycosis mimics inflammatory bowel disease or abscesses. CT reveals thickened bowel, sinus tracts, or fistulas. Delayed diagnosis may lead to surgical complications.
5. DIFFERENTIAL DIAGNOSIS¶
Actinomycosis must be differentiated from malignancy, tuberculosis, mycetoma, botryomycosis, and other chronic infections. Key differentials include: (1) neoplasms (e.g., endometriosis, sarcomas), (2) granulomatous diseases (e.g., TB, sarcoidosis), and (3) bacterial abscesses with sulfur granules (e.g., mycetoma).
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis combines imaging (CT/MRI), microbiological cultures, and histopathology. Key findings include sulfur granules on microscopy, FDG-PET hypermetabolism, and imaging features (e.g., cavitary lesions, sinus tracts). Cultures require anaerobic conditions, and 16S rRNA sequencing improves identification of Actinomyces species.
6.1 Imaging¶
CT/MRI reveals abscesses, sinus tracts, and fibrotic masses. Thoracic disease shows pleural thickening, while pelvic disease may mimic endometriosis or malignancy.
6.2 Microbiological Tests¶
Sulfur granules identified via PAS/GMS/gram stains are diagnostic. Cultures require anaerobic conditions, with 5–7 days for growth. 16S rRNA sequencing enhances species identification.
7. MANAGEMENT & TREATMENT¶
Treatment involves prolonged antimicrobial therapy (6–12 months) with penicillin (3–4 million units IV q4h) or alternatives (tetracyclines, clindamycin). Surgical intervention is reserved for refractory cases or abscesses. Adjunctive therapies include percutaneous drainage and monitoring with CT/MRI.
Table 180-1: Appropriate and Inappropriate Antibiotic Therapy for Actinomycosis¶
| CATEGORY | AGENT |
|---|---|
| Extensive successful clinical experience | Penicillin: 3–4 million units IV q4h |
| Amoxicillin: 500 mg PO q6h | |
| Erythromycin: 500–1000 mg IV q6h or 500 mg PO q6h | |
| Tetracycline: 500 mg PO q6h | |
| Doxycycline: 100 mg IV or PO q12h | |
| Minocycline: 100 mg IV or PO q12h | |
| Clindamycin: 900 mg IV q8h or 300–450 mg PO q6h | |
| Anecdotal successful clinical experience | Ceftriaxone |
| Imipenem-cilastatin | |
| Piperacillin-tazobactam | |
| Linezolid | |
| Rifampin | |
| Meropenem | |
| Tigecycline | |
| Eravacycline | |
| Agents that should be avoided | Metronidazole |
| Aminoglycosides | |
| Oxacillin, dicloxacillin | |
| Cephalexin | |
| Ceftazidime | |
| Daptomycin | |
| Fluoroquinolones |
7.1 Antibiotic Therapy¶
Penicillin is the first-line agent, with oral amoxicillin for maintenance. Alternatives include tetracyclines, clindamycin, or carbapenems for penicillin-allergic patients. Duration is 6–12 months for severe disease.
7.2 Surgical Intervention¶
Surgery is indicated for abscesses, sinus tracts, or when medical therapy fails. Resection of necrotic bone is critical in bisphosphonate-related osteonecrosis.
8. PROGNOSIS & COMPLICATIONS¶
Actinomycosis is curable with prolonged antibiotic therapy, but complications include sinus tracts, abscesses, and misdiagnosis leading to unnecessary surgery. Dissemination to distant organs is rare, though possible. Poor adherence to treatment increases relapse risk.
8.1 Complications¶
Chronic sinus tracts, abscesses, and fibrosis are common. Misdiagnosis as malignancy may lead to radical surgery. Hematogenous spread is rare but can occur in disseminated disease.
8.2 Relapse Risk¶
Relapse is a hallmark of actinomycosis, emphasizing the need for prolonged therapy. CT/MRI monitoring is critical to assess response and prevent recurrence.
9. SPECIAL CONSIDERATIONS¶
Pregnancy, pediatrics, and elderly patients require careful antibiotic selection. IUD users, bisphosphonate recipients, and immunocompromised individuals (e.g., HIV, transplant recipients) are at higher risk. Surgical management must avoid critical structures (e.g., bladder, reproductive organs) in women of childbearing age.
9.1 IUD and Bisphosphonate Use¶
IUDs and bisphosphonates increase risk of pelvic and jaw osteomyelitis. Removal of IUDs is considered if symptoms persist despite antibiotic therapy.
9.2 Immunocompromised Patients¶
HIV, anti-TNF α therapy, and chemotherapy increase susceptibility. Treatment may require broader coverage for opportunistic pathogens.
10. KEY POINTS & CLINICAL PEARLS¶
- Actinomycosis is a polymicrobial, chronic infection mimicking malignancy.
- Sulfur granules and imaging (CT/MRI) are critical for diagnosis.
- Prolonged penicillin therapy (6–12 months) is the mainstay of treatment.
- Surgical intervention is reserved for refractory cases or abscesses.
- IUDs, bisphosphonates, and immunosuppression increase risk.
- Avoid unnecessary surgery by early diagnosis and antimicrobial therapy.